Oruka Therapeutics, Inc. · NASDAQ:ORKA
The Vanguard Group reported a 5.06% stake in Oruka Therapeutics, Inc. (Schedule 13G)
Event Dec 31, 2025 · Filed Jan 30, 2026
The Vanguard Group reported a 5.06% stake in Oruka Therapeutics, Inc., 2,453,530 shares, as a passive investor on Dec 31, 2025. Filed Jan 30, 2026 (Schedule 13G).
- Stake
- 5.06%
- Shares
- 2,453,530
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 5.06% | 2,453,530 |
Source
Related
- Oruka Therapeutics, Inc.
- The Vanguard Group
- Oruka Therapeutics, Inc. shareholders
- Schedule 13G/A · The Vanguard Group · Mar 27, 2026
- Form 4 · Quinlan Paul T · Oct 20, 2026
- Form 4 · Goncalves Joana · Oct 15, 2026
- Form 4 · Agarwal Arjun · Oct 13, 2026
- Form 4 · Klein Lawrence Otto · Oct 2, 2026
- Form 4 · Quinlan Paul T · Sep 21, 2026